A phase 3 trial plans to evaluate Pro-ocular for the treatment of patients with ocular graft-vs-host disease. Signal12 ...
A multidisciplinary, virtual platform showed preliminary feasibility for reducing distress and improving access for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback